Illimis secures funding for GAIA-based Alzheimer’s therapeutics

finance.yahoo.com/news/illimis-secures-funding-gaia-based-152258896.html

Illimis Therapeutics has completed a Series B funding round, securing $42m to expedite the development of its Gas6-mediated Anti-Inflammatory Adaptor (GAIA)-based Alzheimer's disease therapeutics.
The round saw participation from eight existing investors, including Woori Venture…

This story appeared on finance.yahoo.com, 2025-07-14 15:22:58.
The Entire Business World on a Single Page. Free to Use →